Biomarin Pharmaceuticals
(BMRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,836 | -27,101 | -9,448 | -4,371 | 205,819 |
| Depreciation Amortization | 39,082 | 29,521 | 19,169 | 9,665 | 32,190 |
| Income taxes - deferred | 4,363 | 6,844 | 6,993 | 3,910 | -230,577 |
| Accounts receivable | -18,456 | -20,481 | -20,030 | -19,622 | -13,036 |
| Other Working Capital | -25,437 | -29,970 | -26,258 | -22,087 | -42,093 |
| Other Operating Activity | 72,699 | 60,115 | 39,641 | 29,006 | 66,443 |
| Operating Cash Flow | $18,415 | $18,928 | $10,067 | $-3,499 | $18,746 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 66,562 | 11,796 | 13,074 | 9,803 | -15,298 |
| PPE Investments | -73,219 | -64,539 | -8,151 | -6,241 | -49,461 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -32,950 |
| Purchase Of Investment | -1,903 | -1,903 | -1,248 | -593 | -3,633 |
| Purchase Sale Intangibles | -81,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -81,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-89,560 | $-54,646 | $3,675 | $2,969 | $-101,342 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -879 | -524 | -471 | -315 | -195 |
| Common Stock Issued | 33,592 | 23,436 | 11,578 | 3,133 | 33,103 |
| Other Financing Activity | -3,375 | -4,019 | 28 | 415 | -29,404 |
| Financing Cash Flow | $29,338 | $18,893 | $11,135 | $3,233 | $3,504 |
| Beginning Cash Position | 88,079 | 88,079 | 88,079 | 88,079 | 167,171 |
| End Cash Position | 46,272 | 71,254 | 112,956 | 90,782 | 88,079 |
| Net Cash Flow | $-41,807 | $-16,825 | $24,877 | $2,703 | $-79,092 |
| Free Cash Flow | |||||
| Operating Cash Flow | 18,415 | 18,928 | 10,067 | -3,499 | 18,746 |
| Capital Expenditure | -73,219 | -64,539 | -8,151 | -6,241 | -49,461 |
| Free Cash Flow | -54,804 | -45,611 | 1,916 | -9,740 | -30,715 |